This laboratory position involves research and production of radionuclides for medical and other applications. A primary objective of the position is to ensure the University of Washington Radionuclide Production Laboratory (UWRPL) can safely and reliably produce the radionuclide astatine-211 (211At) for use in targeted alpha therapy research at UW and the Fred Hutch Cancer Center. The position also involves production and shipment of radionuclides of interest to other institutions through the National Isotope Development Center (NIDC).
The position supports development of new processes for the production of high specific activity radionuclides, such as rhenium-186 and tin-117m. Additionally, this position is responsible for laboratory equipment maintenance, chemical inventory management and laboratory safety compliance.
UWRPL is a member of the DOE University Isotope Network, and we develop methods for the production of medical radionuclides that are in high demand and short supply in collaboration with the UW Medical Cyclotron Facility.
To Apply or for more information, please visit https://uwhires.admin.washington.edu/ENG/Candidates/default.cfm?szCategory=jobprofile&szOrderID=225581